Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HealthLynked (HLYK) Cost of Revenue (2019 - 2025)

Historic Cost of Revenue for HealthLynked (HLYK) over the last 7 years, with Q3 2025 value amounting to $207068.0.

  • HealthLynked's Cost of Revenue fell 4074.75% to $207068.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 3214.24%. This contributed to the annual value of $1.6 million for FY2024, which is 2940.14% down from last year.
  • HealthLynked's Cost of Revenue amounted to $207068.0 in Q3 2025, which was down 4074.75% from $247395.0 recorded in Q2 2025.
  • Over the past 5 years, HealthLynked's Cost of Revenue peaked at $695300.0 during Q3 2022, and registered a low of $207068.0 during Q3 2025.
  • In the last 5 years, HealthLynked's Cost of Revenue had a median value of $511004.0 in 2021 and averaged $469814.5.
  • As far as peak fluctuations go, HealthLynked's Cost of Revenue soared by 69551.03% in 2021, and later tumbled by 4074.75% in 2025.
  • HealthLynked's Cost of Revenue (Quarter) stood at $558405.0 in 2021, then grew by 19.83% to $669121.0 in 2022, then plummeted by 39.39% to $405555.0 in 2023, then dropped by 17.28% to $335487.0 in 2024, then crashed by 38.28% to $207068.0 in 2025.
  • Its last three reported values are $207068.0 in Q3 2025, $247395.0 for Q2 2025, and $313976.0 during Q1 2025.